PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase

Gommaar D’Hulst(ETH Zurich), Inés Soro-Arnáiz(ETH Zurich), Evi Masschelein(ETH Zurich), Koen Veys(VIB-KU Leuven Center for Cancer Biology), Gillian Fitzgerald(ETH Zurich), Benoit Smeuninx(Arthritis UK), Sung‐Hoon Kim(Seoul National University), Louise Deldicque(UCLouvain), Bert Blaauw(Veneto Institute of Molecular Medicine), Peter Carmeliet(VIB-KU Leuven Center for Cancer Biology), Leigh Breen(Arthritis UK), Peppi Koivunen(University of Oulu), Shimin Zhao(Sichuan University), Katrien De Bock(ETH Zurich)
Nature Communications
January 10, 2020
Cited by 2,306Open Access
Full Text

Abstract

Abstract mTORC1 is an important regulator of muscle mass but how it is modulated by oxygen and nutrients is not completely understood. We show that loss of the prolyl hydroxylase domain isoform 1 oxygen sensor in mice (PHD1 KO ) reduces muscle mass. PHD1 KO muscles show impaired mTORC1 activation in response to leucine whereas mTORC1 activation by growth factors or eccentric contractions was preserved. The ability of PHD1 to promote mTORC1 activity is independent of its hydroxylation activity but is caused by decreased protein content of the leucyl tRNA synthetase (LRS) leucine sensor. Mechanistically, PHD1 interacts with and stabilizes LRS. This interaction is promoted during oxygen and amino acid depletion and protects LRS from degradation. Finally, elderly subjects have lower PHD1 levels and LRS activity in muscle from aged versus young human subjects. In conclusion, PHD1 ensures an optimal mTORC1 response to leucine after episodes of metabolic scarcity.


Related Papers

No related papers found

Powered by citation graph analysis